Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NuoCheng Bio refers to Guangzhou Nuocheng Biological Products, a China-based vaccine and biologics company focused on the research, manufacturing, and sale of human biological products. The company is best known for its freeze-dried human rabies vaccine (Vero cell), which has been described as an independently developed commercial product manufactured using fixed-bed bioreactor and carrier-based Vero cell culture technology. Available evidence indicates the company was founded in 2006 in Guangzhou and later renamed Guangzhou Baiyunshan Biological Products, remaining active as part of the broader Baiyunshan/GPC pharmaceutical ecosystem. Publicly accessible information suggests its commercial focus is concentrated rather than broad, with rabies vaccine as the clearest identified marketed asset. Because detailed English-language disclosures are limited, many pipeline and corporate development fields remain only partially verifiable from open sources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Baiyunshan Biological Products.